Lanean...
Rapamycin and Alzheimer’s disease: Time for a clinical trial?
The drug rapamycin has beneficial effects in a number of animal models of neurodegeneration and aging including mouse models of Alzheimer’s disease. Despite its compelling preclinical record, no clinical trials have tested rapamycin or other mTOR inhibitors in patients with Alzheimer’s disease. We a...
Gorde:
| Argitaratua izan da: | Sci Transl Med |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6762017/ https://ncbi.nlm.nih.gov/pubmed/30674654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aar4289 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|